Media Coverage | National Center for Advancing Translational Sciences

Skip to main content

U.S. Department of Health & Human Services

National Institutes of Health

In the Spotlight

Health-care workers check a patient’s electronic health records on a COVID-19 ward in Cremona, Italy. Credit: Marco Mantovani/Getty

Unlocking the Potential of Health Data to Help Research and Treatments

Nature ∙ 05/03/2022 ∙ CTSA Program

Medical records can be tricky to access because of confidentiality and variability, but data-sharing efforts are helping to overcome these hurdles — without compromising patient privacy. Spurred by the COVID-19 pandemic, researchers have begun to aggregate data from individual institutions in national repositories that are more accessible. In the United States, the National COVID Cohort Collaborative (N3C) is the largest patient-privacy-limited data set in the country’s history, says Melissa Haendel, who co-leads the effort.

May 2022

NIH Announces Antiviral Drug Development Awards
PHARMABIZ.com ∙ 05/20/2022 ∙ Division of Preclinical Innovation
MELD Scoring for Liver Transplants in Need of Sex Adjustment, Study Says
TechiLive.in ∙ 05/19/2022 ∙ CTSA Program
COVID Booster Needed for Broad Protection against Omicron Variants
ScienceDaily ∙ 05/18/2022 ∙ CTSA Program
NIH Awards $577 Million to Establish AViDD Centers for Pathogens of Pandemic Concern
News-Medical.net ∙ 05/18/2022 ∙ Division of Preclinical Innovation
Scientists Identify Characteristics to Better Define Long COVID: Using Machine Learning, Researchers Find Patterns in Electronic Health Record Data to Better Identify Those Likely to Have the Condition
TechiLive.in ∙ 05/17/2022 ∙ CTSA Program
Widely Available AI Could Have Deadly Consequences
WIRED ∙ 05/17/2022 ∙ Division of Preclinical Innovation
Smartwatches and Fitness Bands Reveal Individual Physiological Responses to COVID-19 Vaccine
Travors ∙ 05/12/2022 ∙ CTSA Program
HAIP Chemotherapy or Resection for Multifocal Bile Duct Cancer?
TechiLive.in ∙ 05/12/2022 ∙ NCATS
Do COVID Vaccines Stave Off New Medical Conditions?
TechiLive.in ∙ 05/10/2022 ∙ CTSA Program
Here are Federal Agencies' Steps to IOT Adoption
GovernmentCIO Media & Research ∙ 05/09/2022 ∙ NCATS
Use Case Show Translator’s Potential to Expedite Clinical Research
RENCI ∙ 05/04/2022 ∙ Biomedical Data Translator
Unlocking the Potential of Health Data to Help Research and Treatments
Nature ∙ 05/03/2022 ∙ CTSA Program

April 2022

Insulin Spray Improved Gait, Cognitive Function in Patients with and without Type 2 Diabetes, Clinical Trial Shows
Mirage News ∙ 04/30/2022 ∙ CTSA Program
Researchers Test the Power of Machine Learning to Unravel Long Covid’s Mysteries
STAT ∙ 04/29/2022 ∙ CTSA Program
Ridner Concludes Five-Year, Multi-Site Trial to Assess Lymphedema Prevention
Mirage News ∙ 04/29/2022 ∙ CTSA Program
Synthetic Data Accurately Replicates the Results of Analyses from Real COVID-19 Patient Data
News-Medical.net ∙ 04/27/2022 ∙ CTSA Program
EPA Posts Presentations from Meeting on New Chemicals Collaborative Research Program
The National Law Review ∙ 04/27/2022 ∙ Division of Preclinical Innovation
Team Wins Global Competition to Develop Next-Gen Tools, Improve Public Health Solutions
Mirage News ∙ 04/26/2022 ∙ NCATS
Hydrocortisone Ineffective against Bronchopulmonary Dysplasia in Extremely Preterm Infants
RT Magazine ∙ 04/26/2022 ∙ CTSA Program
Panel Discussion: The High Cost of Rare Diseases
MasupMD ∙ 04/25/2022 ∙ Rare Diseases
EPA Holds Meeting on TSCA New Chemicals Collaborative Research Program
The National Law Review ∙ 04/22/2022 ∙ Division of Preclinical Innovation
Scientists Find Digital Biomarkers That May Be Associated with Vaccine-Induced Immune Responses
Jioforme.com ∙ 04/20/2022 ∙ CTSA Program
Smartwatches and Fitness Bands Reveal Individual Physiological Responses to Covid Vaccine
Mirage News ∙ 04/20/2022 ∙ CTSA Program
Researchers Create 3-D Model for Rare Neuromuscular Disorders, Setting Stage for Clinical Trial
Mirage News ∙ 04/20/2022 ∙ SBIR/STIR, Tissue Chip
Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab
Kaiser Health News ∙ 04/19/2022 ∙ NCATS
What is Birt-Hogg-Dube Syndrome?
News-Medical.net ∙ 04/14/2022 ∙ GARD
New Covid Nasal Spray Outperforms Current Antibody Treatments in Mice
Mirage News ∙ 04/14/2022 ∙ Tissue Chip
A Promising Natural Alternative for Estrogen Deficiency
WFMZ ∙ 04/13/2022 ∙ NCATS
What Is Myotonic Dystrophy (DM)?
WebMD ∙ 04/13/2022 ∙ NCATS
Research in Human Kidney Organoids Finds Target to Prevent Irreversible Kidney Damage
Mirage News ∙ 04/12/2022 ∙ CTSA Program
Is Alzheimer’s Risk Lower with TNF Inhibitors?
TechiLive.in ∙ 04/09/2022 ∙ NCATS
Poverty-Related Stress Linked to Aggressive Head and Neck Cancer
MDedge Federal Practitioner ∙ 04/08/2022 ∙ CTSA Program
Scientists and Communicators Team Up to Increase Clinical Trial Participation
Drug Discovery News ∙ 04/08/2022 ∙ CTSA Program
Researchers Identify Gene That Predicts Breast Cancer Patients’ Treatment Outcomes
Let Life Happen ∙ 04/04/2022 ∙ CTSA Program

March 2022

Examining the Burden of Rare Diseases in the US
Open Access Government ∙ 03/31/2022 ∙ GARD
BabySeq Newborn Screening Project Aims for Increased Diversity in Second Phase
GenomeWeb ∙ 03/31/2022 ∙ NCATS
Early Use of High-Titer Plasma Reduced COVID Hospitalizations
MedPage Today, LLC ∙ 03/30/2022 ∙ CTSA Program
Patients Report Neuropathy after COVID-19
Futurity ∙ 03/30/2022 ∙ CTSA Program
Ivermectin Does Not Reduce Risk of Covid Hospitalization, Large Study Finds
The New York Times ∙ 03/30/2022 ∙ CTSA Program
Symptoms Persisted for Months after a Positive Test For COVID-19
Verve Times ∙ 03/26/2022 ∙ CTSA Program
Study Explores Sleep Apnea, Autoimmune Disease Link
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program
Artificial Intelligence Algorithm Can Accurately Predict Risk and Diagnose Alzheimer’s Disease
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program
Drug Reverses Age-Related Cognitive Decline within Days
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program
Implantable Biotech Shows Promise in War on Cancer, Say NCSU, UNC Researchers
WRAL TechWire ∙ 03/25/2022 ∙ CTSA Program
How Advancing Glioma Cells Scramble Brain Function and Blood Flow
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program
Diet’s Effect on Gut Bacteria Could Play Role in Reducing Alzheimer’s Risk
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program
Alternative Medicine is Widespread among People with Multiple Sclerosis
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program
An Itch to Scratch: Potential Approach to Chronic Itch Problem Identified
Verified News Explorer Network ∙ 03/25/2022 ∙ ADST
Study Find Links Between Inflammation, Menopause, and Depressive Disorder
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program
Low-Carb ‘Keto’ or ‘Atkins-Style’ Diet May Modestly Improve Cognition in Older Adults
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program
Inflammation Seen in Earliest Stages of Parkinson’s Disease, and It Is Different between Men and Women
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program
Imbalance in Gum Bacteria Linked to Alzheimer’s Disease Biomarker
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program
Researchers Identify Gene That Predicts Breast Cancer Patients' Treatment Outcomes
Medindia ∙ 03/24/2022 ∙ CTSA Program
Biomedical Data Platform Moves to the Next Phase
RENCI ∙ 03/24/2022 ∙ Biomedical Data Translator
Here’s How Migraine with Aura Can Affect Your Vision, Muscles, and Speech
MSN ∙ 03/24/2022 ∙ GARD
Shock to the System: Pediatric Type 1 Diabetes Patients and Trauma
Endocrine News ∙ 03/23/2022 ∙ CTSA Program
Angiotensin-Converting Enzyme 2 Allosteric Binders Found to Be Effective against SARS-CoV-2
News-Medical.net ∙ 03/22/2022 ∙ NCATS
A 31-Year-Old Female Presented with a Burning Rash on Upper Arms, Groin, and Axillae
MDedge Dermatology ∙ 03/17/2022 ∙ GARD
Can We Streamline How AAV Gene Therapies Are Developed?
CheckRare ∙ 03/17/2022 ∙ Rare Diseases
RaDaR Serves as Starting Point for Creating Rare Disease Registry
BioNews, Inc. ∙ 03/16/2022 ∙ Rare Diseases
Painkillers That Don’t Kill
Livdose ∙ 03/14/2022 ∙ Division of Preclinical Innovation, Stem Cell Translation Laboratory
Fundraiser to Provide Van for Child in Need
Oxford Observer ∙ 03/14/2022 ∙ GARD
A Woman Found Out through Instagram Her Son Had Uncombable Hair Syndrome. But What Is It?
USA Today ∙ 03/11/2022 ∙ GARD
Keto Diet in MS Tied to Less Disability, Better Quality of Life
Medscape ∙ 03/10/2022 ∙ NCATS
Blunt Secures 7th Consecutive Increase for Life-Saving, Cost-Saving NIH Research
Public Technologies Inc. ∙ 03/09/2022 ∙ CTSA Program
Continuing Face Mask Use Could Save U.S. Billions of Dollars
Mirage News ∙ 03/09/2022 ∙ CTSA Program
Program Awardees: Disruptive Tech Summit – Change Agents Shifting the Landscape
G2Xchange FedCiv ∙ 03/08/2022 ∙ CTSA Program
New Dental Tool Prototype Can Spot the Acidic Conditions That Lead to Cavities
ScienceDaily ∙ 03/08/2022 ∙ NCATS
Maintaining Face Mask Use for Short Time after Hitting Particular COVID-19 Vaccination Targets Offers Major Economic and Health Benefits, Modelling Indicates
The Lancet ∙ 03/08/2022 ∙ CTSA Program
Study Shows Structural Racism Can Result in Poorer Leukemia Outcomes
ReachMD ∙ 03/08/2022 ∙ CTSA Program
Study Maps Neural Pathways for Migraine Pain, Identifies Two Potential CGRP Treatments
Practical Pain Management ∙ 03/07/2022 ∙ Division of Preclinical Innovation
Pregnant Women Have Lingering Depression, Anxiety – Even With Antidepressant Treatment
24HTECH.ASIA ∙ 03/04/2022 ∙ CTSA Program
Kidney Disease Gene Risk Info Aids Prevention in Primary Care
MedPage Today, LLC ∙ 03/04/2022 ∙ CTSA Program
U of M Researchers Find Cohorting Patient Care Model during Pandemic Improved Patient Outcomes
Mirage News ∙ 03/04/2022 ∙ CTSA Program
Cohorting Patient Care Model during Pandemic Improved Patient Outcomes, Researchers Find
ScienceDaily ∙ 03/03/2022 ∙ CTSA Program
Children Affected by Educational Disruptions Experience Mental Health Declines
Pharmacy Times ∙ 03/03/2022 ∙ CTSA Program
Ketogenic Diet May Reduce Disability, Improve Quality of Life in People with MS
Associated Press ∙ 03/01/2022 ∙ NCATS
UAMS Receives National Accreditation for Clinical Informatics Fellowship Program
Log Cabin Democrat ∙ 03/01/2022 ∙ CTSA Program

February 2022

World Rare Disease Day 2022 — “Sharing Your Colours!”
Medindia ∙ 02/28/2022 ∙ Rare Diseases
Rare Disease Day: Updates on Rare Neurological Diseases
https://www.neurologylive.com/view/rare-disease-day-updates-on-rare-neurological-diseases ∙ 02/28/2022 ∙ GARD
AFCEA Panel Tackles Vital Issues
Federal Telemedicine News ∙ 02/28/2022 ∙ CTSA Program, Division of Preclinical Innovation
Rare Disease Day 2022 – A Day to Embrace Innovation (and Wear Your Stripes)
CheckRare ∙ 02/26/2022 ∙ Rare Diseases, RDCRN, TRND
National Youth COVID Study Could Speed Care for Sickest Children
Biz News Post ∙ 02/26/2022 ∙ CTSA Program
Update on FDA Adjustment to Evusheld Dosage Regimen in US
Drugs.com ∙ 02/25/2022 ∙ Division of Preclinical Innovation
UF Health Jacksonville: COVID-19 Trial Studying Effectiveness of Ivermectin, 2 Other Drugs
jacksonville.com ∙ 02/25/2022 ∙ CTSA Program
JACC: High Coronary Artery Calcium, High Cholesterol Increase Heart Attack/Stroke Risk
HMP Global ∙ 02/24/2022 ∙ NCATS
Trial Innovation Network Provides Resources for Investigators – UB Now: News and Views for UB Faculty and Staff
Zipe-Education ∙ 02/24/2022 ∙ CTSA Program
Plant-Based Meat Alternatives Growing but Not Enough to Impact Beef Industry
Phys.org ∙ 02/24/2022 ∙ CTSA Program
The Post-Pandemic Life Sciences Landscape: How a Crisis Enabled Innovation, Collaboration and a New Way Forward
SmartBrief ∙ 02/22/2022 ∙ CTSA Program
UVA Health Joins National Trial Testing Medications for Mild to Moderate Covid
Mirage News ∙ 02/21/2022 ∙ CTSA Program
UVA Participates in Study to Test Controversial Drug for COVID Treatment, Could Have 'Huge Global Impact'
WUSA9.com ∙ 02/21/2022 ∙ CTSA Program
UVA Health Studies Ivermectin, Fluvoxamine to Treat COVID-19
InsideNoVa.com ∙ 02/21/2022 ∙ CTSA Program
The Assistance Fund Opens New Program for Cold Agglutinin Disease
Newswire ∙ 02/21/2022 ∙ GARD
Children with Insomnia Likely to Continue to Suffer as Adults
24 ∙ 02/18/2022 ∙ NCATS
More Studies Confirm Hefty Economic Burden of Rare Diseases
Muscular Dystrophy News ∙ 02/17/2022 ∙ Rare Diseases
Defining Clinical Outcome Pathways
Drug Discovery Today ∙ 02/16/2022 ∙ Biomedical Data Translator
NIH-Backed Nasal Nonaddictive Pain Prospect Clears Early Test
FiercePharma ∙ 02/15/2022 ∙ NCATS
Hillstream BioPharma Provides Business Review with Key Pipeline Updates
Yahoo! Finance ∙ 02/14/2022 ∙ NCATS
The Relationship between Looking and Listening and Human Emotions
Verified News Explorer Network ∙ 02/14/2022 ∙ NCATS
Craving Junk Food after a Sleepless Night?
Verified News Explorer Network ∙ 02/14/2022 ∙ CTSA Program
Novel Melatonin Receptor Molecules Make Possible Therapies to Adjust Biological Clock
Verified News Explorer Network ∙ 02/14/2022 ∙ CTSA Program
Panel Discussion: The High Cost of Rare Diseases
CheckRare ∙ 02/11/2022 ∙ Rare Diseases
Biomarkers Predict Cardiovascular Risk in Chronic Kidney Disease Patients
Medscape ∙ 02/11/2022 ∙ CTSA Program
Autonomous Biohybrid Fish – Made from Human Cardiac Cells – Swims Like the Heart Beats
SciTechDaily ∙ 02/11/2022 ∙ Tissue Chip
Virpax Touts Study Results for Intranasal Spray for Treating Acute, Chronic Pain
Drug Delivery Business News ∙ 02/10/2022 ∙ NCATS
Screening Assays Identify TMPRSS2 Inhibitors from Drug Repurposing Candidates Useful as COVID-19 Therapeutic
News-Medical.net ∙ 02/10/2022 ∙ Division of Preclinical Innovation
Researchers Identify a Potent New Combination of Antiviral Drugs to Combat SARS-CoV-2
News-Medical.net ∙ 02/09/2022 ∙ Division of Preclinical Innovation
Which Kids Are More Likely to Develop MIS-C?
TechiLive.in ∙ 02/09/2022 ∙ CTSA Program
Association between Hormonal Birth Control, Substance Use, and Depression
Frontiers in Psychiatry ∙ 02/08/2022 ∙ CTSA Program
Breast Boils: What They Are, How to Treat Them
HealthCentral ∙ 02/08/2022 ∙ Rare Diseases
Top 5 Startups Enhancing Drug Discovery Using AI and Machine Learning
GreyB Services ∙ 02/07/2022 ∙ NCATS
Pregnant Women with COVID-19 May Be at Greater Risk for Pregnancy Complications
News-Medical.net ∙ 02/07/2022 ∙ CTSA Program
Novel Biosensor Detects Biomarkers Tied to Traumatic Brain Injuries
AZoSensors.com ∙ 02/04/2022 ∙ CTSA Program
Findings Link Migraine Pain to Schwann Cells
Futurity ∙ 02/04/2022 ∙ NCATS
Study Reveals How Migraine Pain Signals Are Generated—and Blocked
Medical Xpress ∙ 02/03/2022 ∙ NCATS
Possible New Method Identified to Assess Severity of TB Infection
Mirage News ∙ 02/03/2022 ∙ CTSA Program
Scientists Test Promising Biosensor Aimed for Use in Brain
ScienceDaily ∙ 02/03/2022 ∙ CTSA Program
Humans and Other Primates Have Evolved Less Sensitive Noses
PLoS ∙ 02/03/2022 ∙ CTSA Program
COVID-19: Study Finds Narrow Window for Convalescent Plasma Effectiveness
MedicalResearch.com ∙ 02/03/2022 ∙ CTSA Program
Transition to Federal Health Data Standards an ‘Unfunded Mandate’ for Smaller Providers
FedScoop ∙ 02/01/2022 ∙ NCATS
Why Each Alzheimer's Patient is Different
Alzheimer's & Dementia Weekly ∙ 02/01/2022 ∙ CTSA Program

January 2022

Researchers Identify a New Protein That Enables SARS-CoV-2 Access into Cells: Findings May Lead to the Development of New Antiviral Therapeutics against COVID-19
TechiAI ∙ 01/28/2022 ∙ CTSA Program
Tool Pinpoints Who May Benefit from COVID Convalescent Plasma
TechiLive.in ∙ 01/27/2022 ∙ CTSA Program
Hypertensive Crisis: Uncontrolled Blood Pressure Is Sending Twice as Many People to the Hospital
SciTechDaily ∙ 01/27/2022 ∙ CTSA Program
Hypertensive Crisis: Uncontrolled Blood Pressure Is Sending Twice as Many People to the Hospital
24HTECH.ASIA ∙ 01/27/2022 ∙ CTSA Program
UAMS Research Team Finds COVID-19 Has Mutation Limits
Log Cabin Democrat ∙ 01/26/2022 ∙ CTSA Program
Let’s Break Down the New Cannabis and COVID-19 Research
MSN ∙ 01/26/2022 ∙ CTSA Program
New Study Validates Benefits of Convalescent Plasma for Some COVID-19 Patients
ScienceDaily ∙ 01/25/2022 ∙ CTSA Program
Local Startup Lands NIH Grant for 3D-printing Collaboration with Virginia Tech
American City Business Journals ∙ 01/25/2022 ∙ SBIR/STIR
Phase and Virginia Tech Partner to Advance Microfluidic 3D Printing
3D Printing Industry ∙ 01/25/2022 ∙ SBIR/STIR
SpaceX CRS-24 Splashes Down Safely after One Month on the ISS, Returns Science to Researchers on Earth
SpaceRef ∙ 01/25/2022 ∙ Tissue Chip
Find Predictors of Heart Disease among Black Americans That Are Shared across Ethnicities
HealthNewsDigest.com ∙ 01/24/2022 ∙ CTSA Program
COVID Treatments: Essentia Health to Help Test 3 Existing Medications — Including Ivermectin
NewsBreak ∙ 01/24/2022 ∙ NCATS
Men Who Worry More May Develop Heart Disease and Diabetes Risk Factors at Younger Ages
Yahoo! Finance ∙ 01/24/2022 ∙ CTSA Program
Should Alcohol Have Warning Labels about Cancer Risk? Most Americans Say ‘Yes’
Mirage News ∙ 01/21/2022 ∙ CTSA Program
Why Scientists Are Racing to Develop More COVID Antivirals
Nature ∙ 01/21/2022 ∙ Division of Preclinical Innovation
Immune Dysfunction Linked to 'Substantial Risk' for Breakthrough COVID-19 Infection
Healio Rheumatology ∙ 01/19/2022 ∙ CTSA Program
How Advancing Glioma Cells Scramble Brain Function and Blood Flow
24HTECH.ASIA ∙ 01/19/2022 ∙ CTSA Program
Disrupted Circadian Rhythms Linked to Later Parkinson’s Diagnoses
24HTECH.ASIA ∙ 01/19/2022 ∙ CTSA Program
Artificial Intelligence Algorithm Can Accurately Predict Risk and Diagnose Alzheimer’s Disease
24HTECH.ASIA ∙ 01/19/2022 ∙ CTSA Program
Everyday Stress May Boost Blood Vessel Dysfunction in People with Depression
24HTECH.ASIA ∙ 01/19/2022 ∙ CTSA Program
Update on Agreement to Supply US with Additional Doses of Evusheld, a Long-Acting Antibody Combination
Executive Bulletin ∙ 01/19/2022 ∙ CTSA Program
E-Cigarette Users Who Test Positive for COVID-19 More Likely to Feel Symptoms, Study Says
Winston-Salem Journal ∙ 01/19/2022 ∙ CTSA Program
Study Finds Vapers More Likely to Experience Heightened COVID Symptoms
La Crosse Tribune ∙ 01/18/2022 ∙ CTSA Program
Survival Rate Increases for Extremely Preterm Infants in NIH-Funded Research Network
Mirage News ∙ 01/18/2022 ∙ NCATS
Do You Smell What I Smell?
24HTECH.ASIA ∙ 01/17/2022 ∙ CTSA Program
Accelerated Cellular Aging Associated with Mortality Seen in Depressed Individuals
24HTECH.ASIA ∙ 01/17/2022 ∙ CTSA Program
Blocking Protein Curbs Memory Loss in Old Mice
24HTECH.ASIA ∙ 01/17/2022 ∙ CTSA Program
Two Halves of the Hippocampus Have Different Gene Activity
24HTECH.ASIA ∙ 01/17/2022 ∙ CTSA Program
Key Genes in the Brain Involved in Encoding Memories Identified
24HTECH.ASIA ∙ 01/17/2022 ∙ CTSA Program
ALERT: 2030 Psychological Agenda – Obedience Training for PreK-Adults Already Global with Billions in Funding for Full Control – Part 3: Spirituality In Education Programming
Equal Opportunity Today ∙ 01/14/2022 ∙ CTSA Program
Public Health Is Missing Crucial Data on LGBTQIA+ People. It’s Not Hard to Collect
STAT ∙ 01/14/2022 ∙ CTSA Program
A New Approach to Train the Brain to Treat Chronic Pain
Psychology Today ∙ 01/13/2022 ∙ NCATS
NIH Sources Sought: NCATS Scientific and Technology Support Services (STSS)
FedHealthIT ∙ 01/13/2022 ∙ NCATS
Teaching Old Drugs New Tricks to Treat COVID-19
Nature Synthesis ∙ 01/12/2022 ∙ Division of Preclinical Innovation
How Rare Disease Research Benefits Everyone
Raconteur ∙ 01/11/2022 ∙ Rare Diseases
This Is Your Brain in Microgravity Image: NASA
PlasticsToday ∙ 01/11/2022 ∙ Tissue Chip
Can a Kidney Failure Risk Equation Better Predict ESKD, Regardless of Race?
Physician’s Weekly ∙ 01/11/2022 ∙ NCATS
Gene Therapies for Rare Diseases
Federal Telemedicine News ∙ 01/10/2022 ∙ Bespoke Gene Therapy Consortium
UCLA-Led Team May Have Found Way to Kill HIV-Infected Cells
KNX News 97.1 FM ∙ 01/10/2022 ∙ CTSA Program
More Evidence Ties Some Antipsychotics to Increased Breast Cancer Risk
Let Life Happen ∙ 01/05/2022 ∙ CTSA Program
Convalescent Plasma May Keep Covid-19 Patients Out of Hospital
Futurity ∙ 01/04/2022 ∙ CTSA Program
Even Healthy Black and Hispanic Women Have More Cesareans than White Women
MDedge ObGyn ∙ 01/04/2022 ∙ CTSA Program
Effectiveness and Scalability of an Electronic Patient-Reported Outcome Measure and Decision Support Tool for Family-Centred and Participation-Focused Early Intervention: PROSPECT Hybrid Type 1 Trial Protocol
Healthcare Newsdesk ∙ 01/04/2022 ∙ CTSA Program
Diagnostic Odyssey: The Lonely Road Walked by Thousands of Coloradans with Rare Disorders
The Gazette ∙ 01/02/2022 ∙ Rare Diseases

December 2021

‘Test-to-Stay,’ Children and Staff Can Safely Remain in School After COVID Exposures
HealthNewsDigest.com ∙ 12/30/2021 ∙ CTSA Program
Which Groups Are the Most Vulnerable to Breakthrough Covid-19 Infection?
Forbes ∙ 12/30/2021 ∙ CTSA Program
With ‘Test-to-Stay,’ Children and Staff Can Safely Remain in School After COVID Exposures
The ABC Science Collaborative ∙ 12/29/2021 ∙ CTSA Program
Emulate's Organs-on-a-chip Head to the International Space Station to Study Gravity's Pull on the Brain
FierceBiotech ∙ 12/29/2021 ∙ Tissue Chip
Gene Therapy is Fighting Rare Diseases in FDA, NIH Program
GovernmentCIO Media & Research ∙ 12/29/2021 ∙ Rare Diseases
Immunocompromised at Higher Risk of COVID Breakthrough Infection: Study
ABC News ∙ 12/28/2021 ∙ CTSA Program
A Patient-First Approach to Specialty Pharmacy
Pharmacy Practice News ∙ 12/23/2021 ∙ GARD
During a COVID-19 Surge, ‘Crisis Standards of Care’ Involve Excruciating Choices and Impossible Ethical Decisions for Hospital Staff
Entrepreneur Media, Inc. ∙ 12/22/2021 ∙ NCATS
Bias, Clinical Inertia May Help Explain Racial Disparities in BP Control
Medscape ∙ 12/21/2021 ∙ CTSA Program
Evusheld Long-Acting Antibody Combination Retains Neutralising Activity against Omicron Variant in Independent FDA Study
PharmiWeb ∙ 12/21/2021 ∙ CTSA Program
Early Use of Convalescent Plasma May Help Outpatients with COVID-19 Avoid Hospitalization
Yahoo! Finance ∙ 12/21/2021 ∙ CTSA Program
Emulate Brain-Chip to Study the Effects of Microgravity on Human Brain Physiology at the International Space Station
Yahoo! Finance ∙ 12/21/2021 ∙ Tissue Chip
Dr. Anne Pariser Provides an Overview of NIH’s Office of Rare Diseases Research
CheckRare ∙ 12/20/2021 ∙ Rare Diseases
Boost for NC Gene Therapy Companies – A New Rare Disease Consortium
WRAL TechWire ∙ 12/20/2021 ∙ Bespoke Gene Therapy Consortium, Rare Diseases
The FDA Modernization Act Can Leverage Technology to Accelerate Drug Discovery and Save Millions of Animals
Forbes ∙ 12/20/2021 ∙ NCATS
ALS Incidence Higher in NFL Players
Physician’s Weekly ∙ 12/17/2021 ∙ CTSA Program
Evusheld Long-Acting Antibody Combination Retains Neutralising Activity against Omicron Variant in Independent FDA Study
World Pharma News ∙ 12/17/2021 ∙ CTSA Program
Prenatal Insomnia: Digital Therapy Can Prevent Postpartum Depression
Medindia ∙ 12/17/2021 ∙ CTSA Program
Study Questions Widely Used Race-Based Formula to Define Lung Disease
Mirage News ∙ 12/17/2021 ∙ CTSA Program
Women Who Practise Self-Compassion Have Lower Risk of Cardiovascular Disease
St Louis News.Net ∙ 12/17/2021 ∙ CTSA Program
The Best Way to Protect Personal Biomedical Data from Hackers Could Be to Treat the Problem Like a Game
Metropolitan Digital ∙ 12/16/2021 ∙ CTSA Program
SpaceX CRS-24 Launching Multiple Life Science Investigations to International Space Station
Parabolic Arc ∙ 12/16/2021 ∙ Tissue Chip
EVUSHELD Long-Acting Antibody Combination Retains Neutralizing Activity against Omicron Variant in Independent FDA Study
Yahoo! Finance ∙ 12/16/2021 ∙ CTSA Program
SLAS Discovery’s December Special Issue, “Assay Guidance Manual for Drug Discovery: Robust or Go Bust” Available Now
Newswise, Inc. ∙ 12/15/2021 ∙ Division of Preclinical Innovation
Not So Rare Diseases: The Cumulative Burden of Underdiagnosis
Pharmafile ∙ 12/14/2021 ∙ Rare Diseases
Therapeutic Enzymes Market 2021: Growth Report Explores Industry Trends, Size, Share & Analysis to 2027 with Dominant Countries Data
openPR ∙ 12/14/2021 ∙ GARD, Rare Diseases
More Evidence Ties Some Antipsychotics to Increased Breast Cancer Risk
Medscape ∙ 12/14/2021 ∙ NCATS
Researchers of CONTAIN Study Say Convalescent Plasma Likely Had Benefit in Early Days of COVID-19; Could Be Used Early in Next Pandemic
ScienceDaily ∙ 12/13/2021 ∙ CTSA Program
LitCoin NLP Challenge by NCATS & NASA
Towards Data Science ∙ 12/10/2021 ∙ NCATS
New CBD Nasal Spray to Target Seizures in Epilepsy
Cannabis Health ∙ 12/09/2021 ∙ NCATS
Antipsychotic Drugs May Increase Risk Of Breast Cancer – Washington University School Of Medicine In St. Louis
Pediatric Daily News ∙ 12/06/2021 ∙ CTSA Program
UAB Scientists Are on Search for the ‘Unknown Known’
Alabama NewsCenter ∙ 12/05/2021 ∙ Biomedical Data Translator
Digital Therapy for Prenatal Insomnia May Prevent Postpartum Depression
Mirage News ∙ 12/04/2021 ∙ CTSA Program
iTHRIV Grants Target Obesity among Latinx Youth, Hepatitis C
Augusta Free Press ∙ 12/04/2021 ∙ CTSA Program
Non–Health Care Municipal Services Cut Severe Maternal Morbidity Rates
Medscape ∙ 12/02/2021 ∙ CTSA Program
After Recovery from Severe COVID-19, Patients Have Greater Risk of Death, UF Study Finds
Yahoo! News ∙ 12/02/2021 ∙ CTSA Program
New Studies Predict How SARS-CoV-2 Mutants Can Evade Vaccines – Harvard Gazette
ExBulletin ∙ 12/02/2021 ∙ CTSA Program
As Omicron Spread Looms, Oral Antivirals Appear to Be One of the Best Defenses — Now We Just Need More
Endpoints News ∙ 12/02/2021 ∙ Division of Preclinical Innovation
UF: Mortality Rate Higher after Severe COVID Bout
Mainstreet Daily News ∙ 12/01/2021 ∙ CTSA Program
Dr Anne Pariser Provides an Overview of NIH’s Office of Rare Diseases Research
CheckRare ∙ 12/01/2021 ∙ Rare Diseases
Doctors Treat Girl’s Genetic Disorder with Repurposed Drug
The Scientist ∙ 12/01/2021 ∙ Rare Diseases
Preeclampsia Ups Womens’ Risks of HFpEF, HFrEF
Physician’s Weekly ∙ 12/01/2021 ∙ CTSA Program

November 2021

Human-on-a-Chip Approach Validated to Model Rare Autoimmune Disease
Drug Discovery World ∙ 11/30/2021 ∙ Tissue Chip
The BGTC is Working to Streamline the Development of Gene Therapies for Rare Diseases
Patient Worthy ∙ 11/23/2021 ∙ Bespoke Gene Therapy Consortium
Santhera and ReveraGen Announce Positive Topline Results with Vamorolone after Completion of the VISION-DMD Study
Yahoo! ∙ 11/23/2021 ∙ NCATS
Stem Cells Help Researchers Create More Complete Genomic Images of Difficult-to-Study Parts of the Brain That Are Involved in Many Important Functions - ScienceDaily
Jioforme.com ∙ 11/21/2021 ∙ CTSA Program
Infineon Calls for What Palantir Already Has
Seeking Alpha ∙ 11/19/2021 ∙ CTSA Program
Franciscan Taking Part in Study of Whether Medications Like Ivermectin Are Eeffective Against COVID
NWI Times ∙ 11/19/2021 ∙ CTSA Program
Loyola University Chicago and Lyfebulb Announce the Winners of the 2021 Innovation Challenge
Yahoo! Finance ∙ 11/18/2021 ∙ CTSA Program
The Role of Gene Therapy in Curing Rare Diseases
Raconteur ∙ 11/18/2021 ∙ Rare Diseases
Chronic Olfactory Loss Plagues Many with COVID-19
TechiLive.in ∙ 11/18/2021 ∙ CTSA Program
Santhera and ReveraGen Announce Successful FDA Pre-NDA Meeting for Vamorolone in Duchenne Muscular Dystrophy
Globe Newswire ∙ 11/17/2021 ∙ NCATS
FDA, NIH, and 15 Private Organizations Join Forces to Increase Effective Gene Therapies for Rare Diseases
Orlando Medical News ∙ 11/17/2021 ∙ Bespoke Gene Therapy Consortium
Franciscan Health Michigan City Joins Nationwide Outpatient Study to Test Medications’ Efficacy against Mild-to-Moderate COVID-19
WIMS ∙ 11/17/2021 ∙ CTSA Program
ICD Codes and Rare Diseases
CheckRare ∙ 11/16/2021 ∙ Rare Diseases
Patient-First Approach to Specialty Relieves Eco-nomic Burden, Improves Outcomes, Enhances Quality of Life
Specialty Pharmacy Continuum ∙ 11/16/2021 ∙ GARD
Higher Risk for COVID-19-Related Hospitalization, Death in HIV-Positive Individuals
MDedge ∙ 11/15/2021 ∙ CTSA Program
Evidence That Type 1 Diabetes May Not Be a Single Disease
Naturopathic Doctor News and Review ∙ 11/15/2021 ∙ CTSA Program
Penn State Secures $25M NCATS Renewal with Focus on Data, Health Equity & Research-as-a-Care Option
TrialSite News ∙ 11/14/2021 ∙ CTSA Program
‘Bespoke Gene Therapy Consortium’ Sets Out to Enable Gene Therapies for Ultra-Rare Diseases
Nature Reviews Drug Discovery ∙ 11/12/2021 ∙ Bespoke Gene Therapy Consortium
Biopharma-Academic Collaborations in 2021
Applied Clinical Trials ∙ 11/12/2021 ∙ NCATS
Should Patients With Stable CHD Be Tested for Mental Stress?
Physician’s Weekly ∙ 11/11/2021 ∙ CTSA Program
Health Equity: Medical Research with Carol Oladele, PhD, MPH, Eliseo J. Pérez-Stable, MD & Consuelo H. Wilkins, MD, MSCI
The Washington Post ∙ 11/10/2021 ∙ CTSA Program
Depression Screening at School Ups Odds of Treatment
Futurity ∙ 11/10/2021 ∙ CTSA Program
Startup Regulonix Pursues Non-Opioid Pain Drug That Indirectly Blocks a Key Ion Channel
FierceBiotech ∙ 11/10/2021 ∙ Division of Preclinical Innovation
Mayo Clinic Co-Leads a New Coalition to Improve Patient Care through Community-Level Clinical Trials
Mayo Clinic ∙ 11/09/2021 ∙ NCATS
bitgrit and CrowdPlat Partner to Host an AI Competition for NCATS
Medium ∙ 11/09/2021 ∙ NCATS
Depression - School-based Screening Increases Identification of, Treatment
HealthNewsDigest.com ∙ 11/08/2021 ∙ CTSA Program
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
Labroots ∙ 11/05/2021 ∙ CTSA Program
Watch: A Conversation on Breakthroughs in Rare Disease Diagnosis
Axios Media ∙ 11/04/2021 ∙ Rare Diseases
NIH Expands Clinical Trials to Test Convalescent Plasma against COVID-19
The World News Monitor ∙ 11/03/2021 ∙ CTSA Program
AstraZeneca Canada Files for Health Canada Authorization of AZD7442 for Prevention Of COVID-19
Yahoo! Finance ∙ 11/03/2021 ∙ CTSA Program
Rare Diseases Cost 3 to 5 Times More than Common Diseases
CheckRare ∙ 11/03/2021 ∙ Rare Diseases
Increasing Effective Gene Therapies For Rare Diseases
Pioneering Minds ∙ 11/02/2021 ∙ Bespoke Gene Therapy Consortium
Rare Disease Research Was Advanced During COVID-19
Patient Worthy ∙ 11/02/2021 ∙ Division of Preclinical Innovation, RDCRN
Sanford Joins NIH Study to Raise Awareness about High Health Care Costs for People with Rare Diseases
Med Magazine ∙ 11/02/2021 ∙ Rare Diseases
Rare Disease Consortium to Focus on Optimizing AAV Gene Therapies
GeneTherapyLive™ ∙ 11/01/2021 ∙ Bespoke Gene Therapy Consortium
A New Era for Translational Research
Applied Clinical Trials ∙ 11/01/2021 ∙ NCATS

October 2021

NIH, FDA and 15 Private Organizations Join Forces to Increase Effective Gene Therapies for Rare Diseases
Mirage News ∙ 10/28/2021 ∙ Bespoke Gene Therapy Consortium
FDA, NIH Announce Bespoke Gene Therapy Consortium to Focus on Rare Diseases
Newsweek ∙ 10/28/2021 ∙ Bespoke Gene Therapy Consortium
FDA, NIH, and 15 Partners Advance Gene Therapy Development in Rare Diseases
Targeted Oncology™ ∙ 10/28/2021 ∙ Bespoke Gene Therapy Consortium
Pfizer, Novartis Sign on to Accelerate Gene Therapies for Rare Diseases with US Agencies
FierceBiotech ∙ 10/28/2021 ∙ Bespoke Gene Therapy Consortium
A Rare Disease Diagnosis Comes with Significant Health Care Costs, Study Shows
Healio ∙ 10/28/2021 ∙ Rare Diseases
Public-Private Partnership Launched to Accelerate Gene Therapies for Rare Diseases
STAT ∙ 10/27/2021 ∙ Bespoke Gene Therapy Consortium
What to Know about Metabolic Disorders
MedicalNewsToday ∙ 10/27/2021 ∙ GARD
Identification of Long COVID Patients Using Big Data
News-Medical.net ∙ 10/26/2021 ∙ CTSA Program
Study Suggests People with Rare Diseases Face Significantly Higher Health Care Costs
PHARMABIZ.com ∙ 10/25/2021 ∙ Rare Diseases
Study Reveals the True Burden of the Hidden Pandemic of Fatty Liver Disease
California News Times ∙ 10/21/2021 ∙ CTSA Program
Pandemic Research Lays Path Forward for Study of Rare Diseases
MedPage Today ∙ 10/21/2021 ∙ Division of Preclinical Innovation, Rare Diseases
TEDDY Study Compares Characteristics of Children Diagnosed with Type 1 Diabetes before and after Age 6
Social & Behavioral Science ∙ 10/21/2021 ∙ CTSA Program
Bacterial Infections in Sinuses of Cystic Fibrosis Patients Share Surprising Similarities
Science Magazine ∙ 10/19/2021 ∙ CTSA Program
Researchers from Kaiser Permanente Washington Health Research Institute Detail New Studies and Findings in the Area of Health Policy and Technology (Usefulness of Mobile Apps for Communication of Genetic Test Results To At-risk Family Members …): Technolo
Insurance Daily News ∙ 10/19/2021 ∙ CTSA Program
Conditionally Reprogrammed Cells and Robotic High-Throughput Screening for Precision Cancer Therapy
Frontiers in Oncology ∙ 10/19/2021 ∙ Tox21
Study: Protection Conferred by Johnson & Johnson Vaccine Virtually Disappears after 5 Months
The Western Journal ∙ 10/18/2021 ∙ NCATS
Telehealth Screening of Infants may Help in Early Autism Support
Medindia ∙ 10/17/2021 ∙ CTSA Program
Officials: Move to Zero Trust Will Look Different for Every Agency
MeriTalk ∙ 10/14/2021 ∙ NCATS
Hormone Widely Used as an Autism Treatment Shows No Benefit
Science Daily ∙ 10/13/2021 ∙ CTSA Program
Type 2 Diabetes Drugs May Lessen Severe Covid-19 Risks
Futurity ∙ 10/12/2021 ∙ CTSA Program
Anticipated Spill from Deteriorating Red Sea Oil Tanker Threatens Public Health
Science Daily ∙ 10/11/2021 ∙ CTSA Program
Goal-Focused Emotion-Regulation Therapy for Young Adult Testicular Cancer Survivors
The ASCO Post ∙ 10/11/2021 ∙ CTSA Program
Oncology Fellows Derive the Greatest Benefit from Advanced Research Training
OncLive ∙ 10/10/2021 ∙ CTSA Program
Neural Network Helps Predict New Drug Combinations to Fight COVID-19
News Binding ∙ 10/09/2021 ∙ Division of Preclinical Innovation
Ivermectin: Why Are There Lawsuits Over This Unproven Drug
c|net ∙ 10/06/2021 ∙ CTSA Program
Thousands of Unknown Chemicals and Substances Found in E-Cigarettes
News-Medical.net ∙ 10/06/2021 ∙ CTSA Program
'Havana Syndrome': A Real and Present Danger
MedPage Today, LLC ∙ 10/05/2021 ∙ NCATS
NIH Continues Collaboration with Palantir Technologies to Support COVID-19 Research
Yahoo! Finance ∙ 10/04/2021 ∙ CTSA Program
AI Technology Automates Tedious Cell Culture Work and Analyses
Drug Discovery & Development ∙ 10/01/2021 ∙ Division of Preclinical Innovation
Merck’s Promising Experimental Covid-19 Drug Raises Hopes for Pill to Fight Virus
POLITICO ∙ 10/01/2021 ∙ Division of Preclinical Innovation
The Mighty's Lambert-Eaton Myasthenic Syndrome (LEMS) Condition Guide
The Mighty ∙ 10/01/2021 ∙ GARD
Can Food Ease Symptoms for People with Bipolar Disorders?
Futurity ∙ 10/01/2021 ∙ CTSA Program

September 2021

Messy, Incomplete U.S. Data Hobbles Pandemic Response
The Washington Post ∙ 09/30/2021 ∙ NCATS
What Happens When the World's Most Popular COVID-19 Dashboard Can't Get Data?
TIME ∙ 09/29/2021 ∙ CTSA Program
A Comparison between Diffuse Idiopathic Skeletal Hyperostosis and Ankylosing Spondylitis
MedicalNewsToday ∙ 09/29/2021 ∙ GARD
AI Identifies Synergistic Drug Combinations For Treating COVID-19
Pioneering Minds ∙ 09/28/2021 ∙ Division of Preclinical Innovation
How to Rescue Big Pharma Drug Castoffs from the Scrap Bin through Nonprofit Partnerships: Report
FierceBiotech ∙ 09/27/2021 ∙ New Therapeutic Uses
Ivermectin and COVID-19: Two Deaths Linked to Use of the Drug in New Mexico
c|net ∙ 09/24/2021 ∙ CTSA Program
U.S. Dept. of Health and Human Services Taps Draper to Develop Lung-on-a-Chip Technology to Study SARS-CoV-2
Yahoo! Finance ∙ 09/23/2021 ∙ Tissue Chip
Large Retrospective Study Tracks Use of HCQ, Remdesivir & Dexamethasone in Real-World Settings
TrialSite News ∙ 09/22/2021 ∙ CTSA Program
Discovery Points toward a New Strategy for Treating Parkinson’s Disease
News-Medical.net ∙ 09/21/2021 ∙ Division of Preclinical Innovation
Ivermectin and COVID-19: What You Need to Know about This Unproven Drug
c|net ∙ 09/15/2021 ∙ CTSA Program
Platelets Are Key to Blood Vessel Damage in Patients with COVID-19
ReachMD ∙ 09/14/2021 ∙ CTSA Program
Mayo, Google Develop a New AI Algorithm to Treat Psychiatric Illness
Gulf Business ∙ 09/14/2021 ∙ CTSA Program
The Space Summit 2021: Up-to-Date Information on the Deployment of Life Sciences Technologies in Space Aboard the ISS - Boston, United States, September 30th, 2021 - October 1st, 2021
Yahoo! Finance ∙ 09/13/2021 ∙ Tissue Chip
A Sizzling Biotech Job Market is Streamlining the Course to a Career in Chemistry
Chemical & Engineering News ∙ 09/12/2021 ∙ Division of Preclinical Innovation
How NIH’s Research-Driving, Centralized Hub for COVID-19 Patient Data is Evolving
Nextgov.com ∙ 09/10/2021 ∙ CTSA Program
Should Early Onset AFib Signal Need for Genetic Testing?
Physician’s Weekly ∙ 09/10/2021 ∙ CTSA Program
Blood Platelets Key to Deadly Organ Damage in COVID-19 Patients
SciTechDaily ∙ 09/09/2021 ∙ CTSA Program
Dr. Palantir: The Great Healthcare Reset
Seeking Alpha ∙ 09/09/2021 ∙ CTSA Program
Platelets Key to Blood Vessel Damage in COVID-19 Patients
The Associated Press ∙ 09/08/2021 ∙ CTSA Program
COVID Vax Elicits Response in 90% of Weakened Immune Systems
Futurity ∙ 09/08/2021 ∙ NCATS
Casting The NET Wide: How Neutrophils Shape Chronic Autoimmune and Inflammatory Diseases
Public Technologies Inc. ∙ 09/08/2021 ∙ Division of Preclinical Innovation
Ivermectin and COVID-19: What's the Deal with This Controversial, Unproven Drug?
c|net ∙ 09/07/2021 ∙ CTSA Program
Most Kids Don’t Know How to Use Their Inhalers. Could More Screen Time be the Solution?
Illinois Science Council ∙ 09/06/2021 ∙ CTSA Program
Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA
The Maravi Post ∙ 09/01/2021 ∙ CTSA Program
Ivermectin and COVID-19: Why People Are Taking This Unproven, Controversial Drug
c|net ∙ 09/01/2021 ∙ CTSA Program

August 2021

Global Microbiome Landscape Market Study 2021: Growing Research and Skyrocketing Venture Funding
Yahoo! Finance ∙ 08/30/2021 ∙ NCATS
Way of Detecting PMP22 Gene Activity May Advance CMT1A Therapies
Charcot-Marie-Tooth News ∙ 08/27/2021 ∙ Division of Preclinical Innovation
Ivermectin and COVID-19: Why Poison Centers Are Getting Calls about This Controversial Drug
c|net ∙ 08/27/2021 ∙ NCATS
Flu Shot Timing: What's Optimal?
Medscape ∙ 08/27/2021 ∙ CTSA Program
School Mask Mandate Wars: Politics (Florida) v. Science (North Carolina)
Science-Based Medicine ∙ 08/26/2021 ∙ NCATS
Heart Transplant: A Slightly More Level Playing Field under New UNOS System
TechiLive.in ∙ 08/26/2021 ∙ NCATS
More and More U.S. Kids Being Diagnosed with Diabetes
TechiLive.in ∙ 08/25/2021 ∙ CTSA Program
Neurologists Find a Link between the Keto Diet and Brain Tumor Growth
Power of Positivity ∙ 08/24/2021 ∙ NCATS
Virpax Breathes Easier with Positive FDA Comments as It Joins the COVID-19 Intranasal Race
BioWorld ∙ 08/20/2021 ∙ NCATS
Calling all Computational Model Developers! Big-data Competition Opens to Help Children at Risk for Severe COVID-19
MedicalCountermeasures.gov ∙ 08/20/2021 ∙ NCATS
Findings from Lehigh Valley Health Network Has Provided New Data on Health and Social Care (Professional Agency Vs Consumer Directed Care Workers: Outcomes In Managed Care)
InsuranceNewsNet.com, Inc. ∙ 08/20/2021 ∙ NCATS
Does Ivermectin Cure COVID-19? What You Need to Know about This Controversial Drug
c|net ∙ 08/12/2021 ∙ CTSA Program
UAMS Research Sheds Light on Vaccine Hesitancy in Arkansas
Log Cabin Democrat ∙ 08/11/2021 ∙ CTSA Program
University of Utah Clinical and Translational Science Institute Expanding Research-Related Improvements in Human Health
TrialSite News ∙ 08/11/2021 ∙ CTSA Program
Washington University Receives NIH Grant for High-Throughput Optical Coherence Tomography (OCT)-Based Imaging Platform for Label-Free, Non-Invasive Characterization of 3-D Tumor Spheroids
Optical Coherence Tomography News ∙ 08/10/2021 ∙ Division of Preclinical Innovation
How is Organ-on-Chip Technology Revolutionizing Medical Research?
MENAFN ∙ 08/09/2021 ∙ Tissue Chip
Ketamine Emerges as Rare Disease Treatment…
CauseACTION ∙ 08/08/2021 ∙ Biomedical Data Translator
Can Ivermectin Treat COVID-19? What You Should Know about This Controversial Drug
c|net ∙ 08/06/2021 ∙ CTSA Program
With a Nudge from AI, Ketamine Emerges as a Potential Rare Disease Treatment
STAT ∙ 08/05/2021 ∙ Biomedical Data Translator
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | NEJM – nejm.org
RocketNews ∙ 08/05/2021 ∙ CTSA Program
1st FDA-Approved Drug to Treat Pruritus from Rare Liver Disease
Jioforme.com ∙ 08/04/2021 ∙ Division of Preclinical Innovation
Accelerating Medical Innovation in Time for Baby Boomers
The Wall Street Journal ∙ 08/03/2021 ∙ NCATS

July 2021

The Lancet: First Prospective Study of Critically Ill COVID-19 Patients from New York City
The World News Monitor ∙ 07/30/2021 ∙ NCATS
Some Young Athletes with Genetic Heart Disease Can Stay in the Game, with Appropriate Care
M.D./alert ∙ 07/29/2021 ∙ CTSA Program
Types of Headaches
YourCareEverywhere ∙ 07/29/2021 ∙ GARD
Hyperimmune Globulin Fails to Prevent Congenital CMV
Physician’s Weekly ∙ 07/29/2021 ∙ CTSA Program
The Space Summit 2021: Major Themes Will Include - Boston, United States, September 30th, 2021 - October 1st, 2021
Benzinga ∙ 07/28/2021 ∙ Tissue Chip
UAMS Researchers Look at Arkansans’ Preferred Covid Testing Sites, Reasons for Not Getting Tested
Arkansas Money and Politics ∙ 07/28/2021 ∙ CTSA Program
UAMS Studies Why Some Seek Virus Testing
GuardOnline.com ∙ 07/28/2021 ∙ CTSA Program
IUD Users Report Low Pregnancy Rates after Placement for Emergency Contraception
MDedge ObGyn ∙ 07/27/2021 ∙ CTSA Program
COVID Cloud Data Fuels Virus Studies
GCN ∙ 07/27/2021 ∙ CTSA Program
OMRF Scientist Seeks Functions of Understudied Genes
Oklahoma's Nursing Times ∙ 07/26/2021 ∙ CTSA Program
UAMS Releases Findings from Statewide COVID-19 Antibody Study
Log Cabin Democrat ∙ 07/21/2021 ∙ CTSA Program
NIH Director Francis Collins and NASA Astronaut Kate Rubins to Keynote Joint Session at ISSRDC
Yahoo! Finance ∙ 07/20/2021 ∙ Tissue Chip
UAMS Says COVID-19 Antibody Tests Show Higher Infection Rates in Minority Groups
Arkansas Times ∙ 07/20/2021 ∙ CTSA Program
Kyowa Kirin Announces EU Approval for the Self-Administration of CRYSVITA®
The Associated Press ∙ 07/19/2021 ∙ GARD
UK Invites People Who Want The Vaccine And People Who Don’t For COVID Transmission Study
WUKY ∙ 07/19/2021 ∙ CTSA Program
ECU Notes: Alumni Take to the Fields
Reflector ∙ 07/17/2021 ∙ NCATS
Kids with Sleep Apnea Risk High Blood Pressure as Teens
Futurity ∙ 07/16/2021 ∙ CTSA Program
COVID-19 Researchers Review 184 Drug Repurposing Candidates
News-Medical.net ∙ 07/15/2021 ∙ Division of Preclinical Innovation
Inadequate Sequencing of SARS-CoV-2 Variants Impedes Global Response to COVID-19
ClinicalNews.org ∙ 07/15/2021 ∙ CTSA Program
Microvi, Nexilico, and UC Berkeley Awarded NIH Funding for Platform Predicting Gut Microbiome Effect on Drug Efficacy
EIN Presswire ∙ 07/13/2021 ∙ NCATS
Ketogenic Diet Results in Metabolic Changes in Astrocytoma
Practical Neurology ∙ 07/13/2021 ∙ CTSA Program
Women in Academic Medicine: Less Pay and Fewer Promotions
MedicalResearch.com ∙ 07/12/2021 ∙ CTSA Program
Fitbit Stats Show Lingering Physiologic Hit after COVID-19
MDEdge Infectious Diseases ∙ 07/09/2021 ∙ CTSA Program
Can Ivermectin Be Used to Treat COVID-19? What You Should Know
c|net ∙ 07/09/2021 ∙ CTSA Program
Brain Cancer? - Could Ketogenic Diet Be Helpful
HealthNewsDigest.com ∙ 07/08/2021 ∙ NCATS

June 2021

NIH Teams Up with Palantir to Build Large Database for COVID-19 Research
SiliconANGLE Media Inc. ∙ 06/30/2021 ∙ NCATS
SARS-CoV-2 Inhibited by Pyrimidine Biosynthesis Inhibitors in Conjunction with Nucleoside Analogs
News-Medical.net ∙ 06/30/2021 ∙ Division of Preclinical Innovation
COVID-19 Vaccines Promise Long Lasting Immunity: Washington University Research
Insurance Journal ∙ 06/29/2021 ∙ NCATS
The Antivirals That Weren’t: Drug Repurposing for COVID-19 Produced Misleading Results
Chemical & Engineering News ∙ 06/29/2021 ∙ Division of Preclinical Innovation
COVID-19 Vaccine Generates Immune Structures Critical for Lasting Immunity
Science Daily ∙ 06/28/2021 ∙ CTSA Program
RNA’s Secret Life Outside the Cell
Verified News Explorer Channel ∙ 06/28/2021 ∙ ExRNA
Study Suggests 5x More People Had COVID-19 Than Were Reported
Shore News Network ∙ 06/26/2021 ∙ CTSA Program
Providing Healthcare in the Digital Age
Augusta Free Press ∙ 06/26/2021 ∙ CTSA Program
Hesperos Validates Utility of Human-on-a-Chip® Approach to Model Nonalcoholic Fatty Liver Disease
Yahoo! Finance ∙ 06/23/2021 ∙ Tissue Chip
Multiple Virus Proteins Implicated in Covid-19 Antibody Response
Physician’s Weekly ∙ 06/23/2021 ∙ NCATS
Researchers Identify Other Parts of the Virus That Could be Targeted by COVID-19 Vaccines
scimex ∙ 06/22/2021 ∙ CTSA Program
CDC to Hold Emergency Meeting Following Reports Linking mRNA Vaccines to Heart Inflammation
NaturalNews.com ∙ 06/22/2021 ∙ NCATS
U.S. to Invest $3 Billion in Pandemic Stockpile
CHEManager International ∙ 06/22/2021 ∙ Division of Preclinical Innovation
Covid-19: Convalescent Plasma Benefits Patients with Hematologic Cancer
Physician’s Weekly ∙ 06/21/2021 ∙ CTSA Program
Blood Cancer Patients with COVID-19 Fare Better with Convalescent Plasma
Mirage News ∙ 06/19/2021 ∙ CTSA Program